NEW YORK (GenomeWeb News) – Orchid Cellmark said today that the Florida Department of Revenue has upheld a contract that had been awarded to the firm to conduct all publicly funded paternity testing for the State of Florida.
The Princeton, NJ-based firm said that the contract had been awarded late last year but was held up by protest of the award by Laboratory Corporation of America, which formerly had provided paternity testing to the state. An administrative law judge oversaw a three-day trial in April, and the Department of Revenue’s decision is based on the findings from those proceedings, said Orchid.
The multi-year contract begins Sept. 1 and is extendable for an additional three years beyond its expiration in 2011. Orchid President and CEO Thomas Bologna said in a statement that the contract is worth approximately $1.2 million per year.
Orchid noted that it previously provided the State of Florida with roughly one-third of its paternity testing services, while LabCorp had serviced the remaining two-thirds of the state.